The five Optum Rx audit triggers independents saw most in 2025

Optum Rx generated more audit notices to independent pharmacies in 2025 than any other PBM by claim volume. The pattern was not random. Optum's audit selection algorithms prioritize specific claim characteristics, and the pharmacies flagged most aggressively tend to share certain patterns in their dispensing history. Understanding those patterns is one of the more useful exercises an independent pharmacy owner can do in 2026.

This article walks through the five most common Optum Rx audit triggers observed across the independent pharmacy segment in the past year, based on the content patterns visible in audit notices. None of this analysis requires insider information — Optum's provider manual and publicly disclosed compliance priorities lay out most of the framework openly.

Trigger 1: High-cost specialty medications

The single most reliable trigger for an Optum Rx audit in 2025 was dispensing volume of high-cost specialty medications, particularly Hepatitis C antivirals, HIV therapeutics, and specialty biologics. The audit threshold does not require that anything be wrong with the dispensing. It requires only that the pharmacy exceed a volume or cost threshold that Optum's algorithms flag for closer review.

If your pharmacy dispenses specialty medications at all, three documentation practices meaningfully reduce audit exposure. Maintain prescriber verification records showing that every specialty prescription is supported by a legitimate prescriber-patient relationship, including clinical notes where available. Document the patient's clinical history as it relates to the dispensing, particularly for indications where medical necessity review is standard. And retain complete chain-of-custody records for every specialty acquisition, because specialty audits often extend into DSCSA documentation.

Trigger 2: Prescriber pattern anomalies

Optum's compliance analytics track prescribing patterns across prescribers and pharmacies. A specific prescriber-pharmacy pair that generates unusual claim volume — relative to the prescriber's specialty, the pharmacy's overall mix, or regional norms — triggers audit selection regularly.

The pharmacy has no control over the prescriber's prescribing patterns. But the pharmacy does control documentation of prescriber verification. For any prescriber who generates significant claim volume at your pharmacy, maintain records of DEA verification, NPI verification, and where applicable, evidence of the prescriber's practice location and specialty. These are the documents Optum requests first when a prescriber-pattern audit begins.

Trigger 3: Early refill patterns

Claims for prescription refills that fall below the days-supply threshold — typically 75% or 80% of the original fill — trigger early-refill audit review. The underlying concern is diversion, but the practical audit is about documentation: whether the pharmacy can produce clinical or administrative justification for the early refill.

Common legitimate reasons for early refills include dosage changes, vacation supplies, insurance plan changes, and medication loss or damage. All of these are acceptable explanations — but only if they are documented at the time of dispensing. Audit responses that reconstruct justifications after the fact are treated skeptically.

The protective practice is to require a brief documentation entry for every early refill at the time it is dispensed, capturing the reason and any supporting information. This takes 30 seconds per early refill and eliminates most early-refill audit findings.

Trigger 4: Adherence score outliers

Optum, like other PBMs, tracks pharmacy-level adherence metrics for diabetes, statin, and hypertension medications. These metrics feed both DIR fee calculations and audit selection. A pharmacy with unusually high or unusually low adherence scores relative to peer groups attracts attention in both directions.

Unusually low adherence scores suggest potential dispensing or patient counseling issues. Unusually high adherence scores — particularly those that diverge significantly from the plan population average — can suggest data reporting issues or, in rare cases, allegations of claim manipulation.

The pharmacy defense is transparent reporting. Ensure that your pharmacy management system reports adherence data consistently with how claims were actually filled. Do not attempt to optimize adherence metrics through dispensing practices that diverge from standard clinical care, because the optimization itself can trigger the audit.

Trigger 5: Documentation time-stamp inconsistencies

This trigger is the most technical and the least discussed. Optum's audit contractors frequently examine the timestamps on claim submissions and compare them to dispensing records. Inconsistencies — where a claim was submitted hours or days before the actual dispensing record — can trigger broader documentation review.

These inconsistencies often originate from pharmacy management system configuration issues rather than intentional action. A claim submitted at the time of prescription receipt rather than at the time of actual dispensing creates the appearance of time-stamp divergence. During normal operations, this is invisible. During audit, it becomes a finding.

The fix is system configuration: claims should be submitted at the time of actual dispensing, and dispensing records should carry timestamps that align with the claim submission timestamp. Most pharmacy management systems support this configuration, but the default settings often do not enforce it.

What the 2026 enforcement climate adds

Three factors are intensifying Optum Rx audit activity in 2026. The first is CMS's broader increased scrutiny of Medicare Part D claim patterns, which flows downstream into PBM audit priorities. The second is the continued refinement of automated audit selection, which now surfaces combinations of patterns — for example, a pharmacy that has both specialty dispensing and a prescriber-pattern anomaly receives faster audit selection than one with only a single trigger. The third is the expansion of audit scope when findings are identified — a pharmacy that receives a finding on one trigger is more likely to receive expanded audit scope covering adjacent triggers.

The practical conclusion is that documentation discipline matters more in 2026 than it did in previous years. A pharmacy that operates cleanly but documents inconsistently can still generate findings. A pharmacy that documents consistently is far better positioned to respond to any specific finding quickly and with the evidence PBMs actually accept.